Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chiesi
Pharma
Italian pharma Angelini scoops up Catalyst in $4.1B deal
Italy’s Angelini Pharma will acquire Florida-based rare disease specialist Catalyst and its potential blockbuster Firdapse for $4.1 billion.
Kevin Dunleavy
May 7, 2026 12:00pm
Chiesi grows rare disease ambitions with $1.9B KalVista buyout
Apr 29, 2026 10:01am
Chiesi, Viatris among collaborators on BIO video series
Jul 28, 2025 12:00pm
Chiesi unveils €430M investment in new Italian inhaler facility
Mar 27, 2025 10:47am
Sanofi, Pfizer, AZ lead biopharma industry investment in France
May 13, 2024 11:00am
Chiesi survey shows how Fabry drugs are failing patients
Apr 24, 2024 10:25am
